Starpharma Holdings (SPL) Director Trades
Insider activity from ASX Appendix 3Y filings.
- Trades shown
- 26
- Bought (value)
- $26,845,462,919
- Sold (value)
- $0
- Net sentiment
- +$26,845,462,919
| Date | Director | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-05 | C Maley | Buy | — | — | — | View |
| 2026-09-30 | Cheryl Maley | Exercise | 702,768 | — | — | View |
| 2026-08-13 | R Basser | Buy | — | — | — | View |
| 2026-08-13 | R Thomas | Buy | — | — | — | View |
| 2026-08-13 | L Cheng | Buy | — | — | — | View |
| 2026-08-13 | J Davies | Buy | — | — | — | View |
| 2026-08-13 | C Maley | Buy | — | — | — | View |
| 2026-08-11 | Russell Basser | Buy | 36,191 | $0.57 | $20,629 | View |
| 2026-08-11 | Robert B. Thomas | Buy | 350,001 | $0.57 | $199,501 | View |
| 2026-08-11 | Jeff Davies | Buy | 117,291 | $0.57 | $66,856 | View |
| 2026-08-11 | Cheryl Maley | Buy | 16,667 | $0.57 | $9,500 | View |
| 2026-08-11 | Lynda Cheng | Buy | 22,741 | $0.57 | $12,962 | View |
| 2025-12-17 | C Maley | Buy | — | — | — | View |
| 2025-12-12 | Cheryl Maley | other | 6,525,939 | — | — | View |
| 2025-10-21 | R Thomas | Buy | — | — | — | View |
| 2025-10-16 | Robert B Thomas | Buy | 450,000 | $0.2788 | $125,471 | View |
| 2025-10-06 | C Maley | Buy | — | — | — | View |
| 2025-09-30 | Cheryl Maley | other | 439,752 | — | — | View |
| 2024-12-12 | Ms Cheryl Maley | Buy | — | — | — | View |
| 2024-12-11 | Cheryl Maley | other | 5,202,703 | — | — | View |
| 2024-11-06 | Unknown Director | Buy | — | — | — | View |
| 2024-11-05 | Robert B Thomas | Buy | 300,000 | $0.0933 | $28,000 | View |
| 2024-10-24 | R Thomas | Buy | — | — | — | View |
| 2024-10-23 | Robert B. Thomas | Buy | 500,000 | $46,250.00 | $23,125,000,000 | View |
| 2024-09-16 | Dr Russell Basser | Buy | — | — | — | View |
| 2024-09-13 | Dr Russell Basser | Buy | 200,000 | $18,600.00 | $3,720,000,000 | View |
Source: ASX Appendix 3Y filings (Corporations Act s205G). Director trades must be lodged with the ASX within 14 days of the change in interest. See the official methodology.